An engineered IgM antibody targeting CD20 has enhanced complement-dependent cytotoxicity compared with an IgG. - Hart KC; Hinton PR; Manlusoc M; Carlin KB; Schneider S; Kotturi MF; Baliga R; Keyt BA (Experimental hematology, 2025)